The single interchain disulphide bond in platelet glycoprotein lIb (GPIIb) is accessible to extracellular reductants, and selective cleavage does not liberate GPIIba from platelet plasma membrane, confirming that non-covalent interactions contribute to maintaining attachment of this subunit to the membrane. Eosin-maleimide labelling of isolated GPIIb after selective cleavage of this interchain disulphide bond, followed by full reduction and alkylation, CNBr cleavage, and analysis of the cleavage products allowed us to establish that this interchain disulphide bridge is formed between GPIIbfl (GPIIb f-subunit) Cys-9 and GPIIba Cys-826, and this conclusion was confirmed by independent routes. The other two cysteines of GPIIb,l form the single intrachain disulphide bond in this subunit. Last, the intrachain disulphides in GPIIba (GPIIb a-subunit) are distributed in four main peptide domains which are not disulphide-bonded among themselves. The linear epitope for monoclonal antibody Ml is localized between Pro-4 and Met-24 (or Met-31) of GPIIb,I. The linear epitope for M3 is situated between Cys-826 and the C-terminus of GPIIba. The M4 epitope is also linear and localized somewhere between residues 115 and 285 of GPIIba. Finally, the epitopes for M5 and M6 are somewhere between Cys-608 and Met-704, within a 35 kDa membrane-bound chymotryptic product of digestion of GPIIb in whole platelets. The N-terminal amino acid sequences determined for eight different cleavage products of GPIIba and GPIIb,i agree with the corresponding amino acid sequences predicted by cDNA sequence for human-erythroleukaemic-cell
INTRODUCTION
Glycoprotein Ilb (GPIIb) is a 136.5 kDa major component of platelet plasma membrane (Clemetson & McGregor, 1987; Usobiaga et al., 1987) , which together with glycoprotein lIla (GPIIIa, 91.5 kDa) serves as an inducible receptor for fibrinogen and other adhesive proteins, and plays a primary role in platelet aggregation (Nurden & Caen, 1974; Phillips et al., 1975) . These two glycoproteins have been isolated and characterized both as individual glycoproteins and as a GPIIb-GPIIIa complex (Leung et al., 1981; McEver et al., 1982; Jennings & Phillips, 1982; Eirin et al., 1986) . In previous work Usobiaga et al., 1987) we reported the isolation, the amino acid and sugar composition and the molecular characterization of the cc-(GPIIbca, 114 kDa) and ,- (GPIIb, 8, 22 .5 kDa) subunits of GPIIb. We also found that GPIIba and GPIIbfl are joined by a single disulphide bond and that the remaining half-cystine residues participate in intrachain bonds, six in GPIIba and one in GPIIb,.
GPIIb and GPIIIa are derived from the translation of two distinct mRNAs that are found in both human erythroleukaemic (HEL) cells (Bray et al., 1986) and megakaryocytes (Duperray et al., 1987) . Increasing structural and immunochemical evidence has led to the hypothesis that the GPIIb-GPIIIa complex belongs to a superfamily of heterodimeric glycoproteins of similar sequence comprising cellular-adhesion receptors (cytoadhesins), integrins and leukocyte-adhesion receptors (Fitzgerald et al., 1987; Ginsberg et al., 1988; Uzan et al., 1988) .
In the present study we established (i) the position in the a-and ,-subunits of the half-cystine residues forming the interchain disulphide bridge in GPIIb and its extracellular location, (ii) the position of the single intrachain disulphide bond in GPIIbfl and also that for some of the intrachain disulphide bonds in GPIIba, and (iii) the localization of the epitopes for several anti-GPIIb
Abbreviations used: GPIIba and GPIIbfl, the a-and fl-subunits of glycoprotein IIb (GPIIb) , after selective reduction of the single disulphide joining them and further carboxymethylation; CM-GPIIba and CM-GPIIbfl, a-and fl-subunits of GPIIb at any other degree of reduction, carboxymethylation and association; PMSF, phenylmethanesulphonyl fluoride; HEL, human erythroleukaemic-cell line; GPIIIa, glycoprotein Vol. 261 551 monoclonal antibodies. We also confirmed previous findings that neither the f-nor the a-subunit is liberated from the membrane after selective cleavage of the interchain disulphide bond (Calvete & GonzdlezRodriguez, 1986 ).
MATERIALS AND METHODS Materials Eosin-maleimide was from Molecular Probes (Junction City, OR, U.S.A.). Chymotrypsin was from Sigma (St. Louis, MO, U.S.A.). All chemicals and biochemicals were of analytical or chromatographic grade. Chromatographic columns and buffers, as well as the preparation of human platelets, platelet plasma membranes and the isolation of GPIIb and the a-and /1-subunits of GPIIb in their fully reduced, partially reduced and alkylated and fully alkylated forms, were as described previously (Calvete & Gonzailez-Rodriguez, 1986; Eirin et al., 1986) .
Analytical methods
Assay of proteins (Markwell et al., 1978) , amino acid analysis, free-thiol (Ellman, 1959) and disulphide-group (Zahler & Cleland, 1968) determinations, labelling with eosin-maleimide and measurement of bound eosin, and SDS/polyacrylamide-gel electrophoresis (Laemmli, 1970) , were done as described previously (Calvete & Gonzailez-Rodriguez, 1986; Eirin et al., 1986) . Isolation of peptides by electroelution from SDS/polyacrylamidegel-electrophoretic bands was carried out as described by Hunkapiller et al. (1983) .
Immunoelectroblotting
After gel electrophoresis the glycoprotein bands were transferred to nitrocellulose by a standard procedure (Towbin et al., 1979) at 250 mA for up to 5 h. The first antibodies used, all in the form of the 50 00-satd.-(NH4)SO4-precipitated fraction of ascitic fluids, were mouse anti-GPIIba (M3, M4, M5, M6) and anti-GPIIbfl (MI) monoclonal antibodies, prepared by using either total GPIIb or the isolated subunits, according to immunization and fusion protocols and screening assays described previously (Melero & Gonzailez-Rodriguez, 1984; Calvete & Gonzailez-Rodriguez, 1986; Calvete et al., 1986a,b) . The second antibody was goat anti-(mouse IgG) IgG. Detection was effected by autoradiography using X-Omat films (Kodak) after incubation with 1251-protein A. Automated Edman degradation Automated Edman degradation was done as described previously (Edman & Henschen, 1975; Calvete et al., 1988) . The phenylthiohydantoin (PTH) derivatives of the amino acids were analysed by reverse-phase h.p.l.c. using either a Beckman Ultrasphere PTH column (Hew et al., 1986) or a Spherisorb ODSII column (Henschen, 1986) . Thiol modification with 4-vinylpyridine and identification of the S-/I-4-pyridylethylcysteine during amino acid and sequence analysis was done as described by Henschen (1986) . Reduction and carboxymethylation of whole platelets
Platelets were washed twice in 20 mM-Tris/HCl/ 150 mM-NaCl, pH 8.0, and resuspended in the same buffer at 2 x 109 platelets/ml. Samples (1 ml) of the platelet suspension were reduced for I h at room temperature with increasing molar excesses of dithioerythritol over the theoretical half-cystine contents of GPIIb and GPIIIa in platelets. The following data were used: GPIIb (136.5 kDa, 16 half-cystine residues) and GPIIIa (91.5 kDa, 50 half-cystine residues) represent 1.7 and 1.20% (w/w) respectively of the total platelet proteins (Eirin et al., 1986) Reduction was followed by alkylation for 30 min with a 5-fold molar excess of iodoacetate over reductant. The reduced and alkylated platelets were washed twice, resuspended and sonicated in the same buffer, and the particulate fraction was obtained by highspeed ultracentrifugation at 160000 g (rav, 65 mm) for 1 h at 4 'C. Digestion of whole platelets with chymotrypsin Platelets were washed in 10 mM-Tris/HCl/150 mmNaCl/1 mM-EDTA, pH 7.4, and resuspended at 5 x I09 platelets/ml in the same buffer. The platelet suspension was incubated at 37°C with chymotrypsin (0.2 mg/ml). After 5 min the digestion was stopped with PMSF (25 mol/mol of chymotrypsin). Digested platelets were centrifuged at 10000 g (ray, 75 mm) for 10 min at 4 'C. The supernatant containing the soluble products of digestion was dialysed against Milli Q water at 4 'C and freeze-dried. The digested platelets were resuspended and sonicated in the same buffer, and the particulate fraction was obtained by high-speed ultracentrifugation as above.
Reduction and carboxymethylation of isolated GPIIb
Pure GPIIb (5 mg/ml) in 50 mM-Tris/HCI/2 mM-EDTA/0. I 0 SDS, pH 8.0, was reduced at room temperature for 2 h with a 5-fold molar excess of dithioerythritol over the theoretical half-cystine content of GPIIb, followed by alkylation with a 1.5-fold molar excess of eosin-maleimide over reductant for 2 h in the dark. The sample was passed first through a Sephadex G-50 column (1 cm x 40 cm) to separate free from bound eosin and afterwards through a Sephacryl S-200 column (1.5 cm x 100 cm) to isolate the eosin-labelled a-and /Jsubunits (Calvete & Gonzailez-Rodriguez, 1986 ). The isolated subunits were further fully reduced with a 150-fold molar excess of dithioerythritol over their theoretical half-cystine contents and alkylated in the same buffer as follows: the a-subunit with a 1.5-fold molar excess of iodoacetate over reducing agent, and the fl-subunit with a 1.5 molar excess of 4-vinylpyridine, as described by Henschen (1986) . The subunits were finally dialysed against Milli Q water and freeze-dried. 
RESULTS
Di-thioerythrithol access from the outside of the platelet to the GPIIb interchain disulphide bond Fig. 1 shows the extracellular reduction of GPIIb in intact platelets by dithioerythritol. The supernatant and pellet after sonication of reduced, alkylated and washed platelets (see the Materials and methods section) were analysed by SDS/polyacrylamide-gel electrophoresis, followed by immunoelectroblotting with GPIIb-specific monoclonal antibodies: Ml for recognition of GPIIbfl, and M3 for recognition of GPIIba. With a 40-fold molar excess of dithioerythritol over the half-cystine content of GPIIb and GPIIIa in platelets (Eirin et al., 1986) , GPIIb is already partially cleaved (results not shown). With a 100-fold molar excess of reducing agent, GPIIb is totally cleaved into its two subtnits, both of which remain in the membrane fraction (Fig. 1) . The electrophoretic mobility of GPIIba after reduction and carboxymethylation in platelets is lower than the mobilities of unmodified GPIIb (Fig. lb) and of GPIIba after full reduction and carboxymethylation in solution (Calvete & Gonzailez-Rodriguez, 1986 ).
Localization in the fsubunit of the half-cystine residue forming the interchain disulphide bridge in GPIIb and of the single intrachain disulphide bond When isolated GPIIb is reduced with a 5-fold molar excess of dithioerythritol over total half-cystine residues (determined by amino acid analysis of GPIIb) and further alkylated with a 1.5-fold molar excess of eosin-maleimide (Calvete & Gonzailez-Rodriguez, 1986 ), the molar content ofeosin in the a-and fl-subunits after their separation by size-exclusion chromatography was 1.9 in GPIIba and 0.95 in GPIIb,. If eosin-labelled GPIIb, was then totally reduced with a 150-fold molar excess of dithioerythritol and further alkylated with 4-vinylpyridine (see the Materials and methods section), the N-terminal-sequence analysis of this subunit gave the following sequence:
where a gap is found in position 9 and S-/?-4-pyridylethylcysteine residues (Cys-Pyr) are found in positions 14 and 19. This, together with the N-terminal sequence predicted for unmodified GPIIb,J Fig. 4 . Chromatographic isolation and electrophoretic analysis of the 95 kDa soluble product of chymotryptic digestion of GPIIb in whole platelets Digestion of whole platelets with chymotrypsin, isolation of the soluble products of digestion and SDS/polyacrylamide-gel electrophoresis were effected as described in the Materials and methods section. Gels containing 70% polyacrylamide and Coomassie Blue staining were used. Abbreviations: Myo, myosin; Act, actin. Panel A, electrophoretic analysis of the unreduced soluble products of chymotryptic digestion of whole platelets, after size-exclusion chromatography on a column (2.5 cm x 150 cm) of Sephacryl S-300 in 0.1 M-phosphate/0.1 0% SDS/I mM-EDTA/2 mM-PMSF/0.025 % NaN3 buffer, pH 6.8. viewed under a u.v. lamp, had apparent molecular masses of 35, 19 and 18 kDa respectively (results not shown). The 35 and 19 kDa fragments are recognized by antiGPIIba monoclonal antibodies M4 and M3 respectively. The three peptides were isolated by electroelution (Fig. 2) and their N-terminal sequence and amino acid content determined.
The 35 kDa peptide has the same N-terminal sequence as that of isolated GPIIba, namely Leu-Asn-Leu-AspPro. The N-terminal sequence of the 19 kDa peptide is Leu-Val-Ser-Val-Gly, which is identical with the sequence from residues 704-708 in the GPIIb amino acid sequence, as predicted from the sequence of identified cDNA clones from HEL cells and megakaryocytes Uzan et al., 1988) . Therefore the 19 kDa peptide corresponds tentatively to residues 704 onwards in this predicted sequence. The N-terminal sequence for the 18 kDa fragment Glu-Ser-Arg-Ala-Asp, which correspond tentatively to a peptide from residue 314 to 489 in the HEL GPIIb sequence. The amino acid composition of the three peptides ( Localization of the peptide carrying the half-cystine residue involved in the interchain bridge. Platelets digested with chymotrypsin were pelleted at low speed, and the supernatant, containing the soluble products of digestion, was freeze-dried after being dialysed against distilled water (see the Materials and methods section). The digested pellets were further sonicated and the particulate fraction obtained by high-speed differential centrifugation. SDS/polyacrylamide-gel electrophoresis of the unreduced soluble products of platelet digestion, followed by immunoelectroblotting, shows a product, of apparent molecular mass 95 kDa, recognized by M4 (see below). Similar analysis of the unreduced particulate fraction shows two products with apparent molecular masses of 85 and 65 kDa, both of which were recognized by monoclonal antibodies M5 and M6 (Fig. 3a) , the 85 kDapeptide being recognized, in addition, by M1. After reduction of this peptide, Ml recognizes a product with the same electrophoretic mobility as GPIIb,8 (Fig. 3c ).
This tells us that the half-cystine residue involved in the interchain disulphide bridge of GPIIb cannot be in the soluble fragment of 95 kDa liberated in the supernatant after early digestion ofwhole platelets with chymotrypsin.
The 95 kDa fragment was isolated by a size-exclusion chromatography on Sephacryl 300 (Fig. 4, panel A) Fig. 5 . Analysis by immunoelectroblotting of the soluble products of chymotryptic digestion of GPIIb in whole platelets, using monoclonal antibody M4 The isolation of the 95 kDa soluble product of chymotryptic digestion of GPIIb in whole platelets was done as described in Fig. 4 . SDS/polyacrylamide-gel electrophoresis, electroelution and immunoelectroblotting were done as described in the Materials and methods section. Gels containing 7 % polacrylamide, M4 at 1: 1000 dilution and sample reduction (when indicated) with 1 % 2-mercaptoethanol (2 min, 100°C) were used. Lane a, (Fig. 4, panel B) . Monoclonal antibody M4 recognizes 110, 40/45, and 28 kDa fragments after immunoelectroblotting (Fig. 5) . Peptides 110 and 28 kDa were further isolated by electroelution (Fig. 5, cannot contain the half-cystine residue joining the a-and f-subunits in GPIIb. Thus the only candidate left is the 19 kDa peptide recognized by M3.
The N-terminal sequence analysis of the 28 kDa product shows heterogeneity in the cleavage point, Val"5-Leu-Glu-Lys-Thr-Glu-Glu-Ala being the major sequence, and Lys1"8-Thr-Glu-Glu-Ala and Ala'33-GlnPro-Glu-Ser being minor ones. This, together with the amino acid composition of this product (Table 1) , led us to identify it with the peptide stretch beginning at residue 115.
Further evidence on the identification of the a-chain half-cystine residue involved in the interchain bridge. When the unreduced CNBr products of cleavage of whole GPIIb were analysed by immunoelectroblotting, monoclonal antibodies M1 and M3 recognized a peptide of apparent molecular mass 20 kDa, whereas M4 recognized a peptide of 35 kDa (Fig. 6) . When the reduced CNBr products were analysed, M4 still recognized the 35 kDa peptide, whereas MI now recognized a peptide migrating with the electrophoretic front (Fig. 6) 
DISCUSSION
In Scheme 1, and on the basis of the amino acid sequence predicted from the cDNA sequence for HEL and megakaryocyte GPIIb Uzan et al., 1988) we outline the information obtained in the present work on the localization in platelet GPIIb of the interchain and intrachain disulphide bonds and of the epitopes for some monoclonal antibodies. SDS/polyacrylamide-gel electrophoresis in 12.5 % polyacrylamide gels and immunoelectroblotting using Ml at 1: 200 dilution and sample reduction with 1 % 2-mercaptoethanol (2 min, 100°C) were carried out as indicated in the Materials and methods section. Lane a, band 1 and band 2 of CM-GPIIb/? ). carrier of the half-cystine residue involved in the interchain disulphide bridge, and pointed once more to the 19 kDa CNBr product of cleavage of GPIIba and therefore to the single cysteine residue in this fragment, which corresponds to the Cys-826 in the HEL GPIIb sequence.
Localization of the epitope for anti-GPIIbfp monoclonal antibody Ml
When the products of 4 h cleavage of fully reduced and carboxymethylated GPIIbf with CNBr were separated on a column (1 cm x 150 cm) of Sephadex G-75 in 0. 1 M-phosphate/0. 1 % SDS buffer, pH 7.0, two fractions were obtained of apparent molecular masses 22 and 18 kDa; N-terminal sequence analysis showed clearly that the larger fraction is a mixture of three peptides whose most probable N-terminal sequences, after consideration of their apparent molecular masses, N-terminal sequence found here for GPIIbfl, and the cDNA predicted sequence for this subunit Uzan et al., 1988) were: Pro-Val-Leu-Val-Ser (residues 4-8); Ser-Ala-Pro-Cys (residues 11-14); Val-Thr-ValLeu-Ala (residues 32-36). The smaller fraction contained mainly a single peptide whose N-terminal sequence (ValThr-Val-Leu-Ala-Phe) is the same as one of those found in the larger fraction and which corresponds to the peptide stretch beginning at residue 32 of GPIIbf. When these two fractions were subjected to analysis by immunoelectroblotting, only the larger fraction was recognized by monoclonal antibody Ml (Fig. 7) . There-
GPIIb interchain disulphide bond
First, we deal with disulphide-bond localization. Given that the cDNA sequence for HEL and megakaryocyte GPIIba do not predict any transmembrane domain, it was reasonable to expect that the single disulphide bond joining the a-and f-subunits in GPIIb (Calvete & Gonzailez-Rodriguez, 1986; footnote in Fitzgerald et al., 1987) was extracellular. However, what it was not possible to predict was whether or not this disulphide bond was accessible to reduction from the extracellular medium, and whether or not GPIIba would be liberated from the membrane after cleavage of the single interchain bond of GPIIb. Here we confirm our previous finding that, after its cleavage, the a-chain remains attached to the membrane and that this disulphide bond is accessible to extracellular reductants. These findings imply that, besides the interchain disulphide bridge, other non-covalent interactions of GPIIba with other molecular components of the platelet plasma membrane (GPIIb,f, GPIIIa, lipids etc.) contribute to maintenance of the binding of this subunit to the membrane.
Several lines of evidence permit us to establish that the single interchain disulphide bridge in GPIIb is formed between GPIIbfl Cys-9 and GPIIba Cys-826. Eosin-maleimide labelling after selective cleavage of the interchain disulphide, followed by isolation, full reduction and alkylation and N-terminal sequence analysis of the fl-subunit, led us to conclude that Cys-9 of this subunit, the only eosin-labelled cysteine in the f-chain, is involved in the interchain disulphide bridge, whereas the two remaining cysteine residues form the single intrachain disulphide bond in GPIIb,f. 
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-CM-18Nr a CNBr ,Cr?Tr 5---' -' 137/) Scheme 1. Cleavage patterns and localization of disulphide bonds and epitopes for monoclonal antibodies (MI, M3, M4, M5 and M6) in human platelet GPIIb Cleavage fragments are referred by their apparent molecular masses (kDa). The GPIIb linear amino acid sequence was taken to be identical with the cDNA-deduced amino acid sequence for HEL GPIIb Intrachain disulphide bonds in GPIIbx At least four main peptide stretches non-disulphidebonded among themselves can be outlined in GPIIba (Scheme 1). The N-terminal stretch is represented by the 35 kDa CNBr peptide and contains the first six cysteine residues. A central region, containing four cysteine residues, stretches from Met-285 to the chymotryptic cleavage point of GPIIb in whole platelets; that is, the Cterminal end of Ch-95 kDa soluble peptide (tentatively assigned to . A further stretch from Asn-570 up to Met-703 contains four cysteine residues. Finally, the C-terminal stretch, from Leu-704 up to the C-terminal end of GPIIbcz, has within it Cys-826 only. Given the structural similarity of the two-chain a-subunits found so far among Arg-Gly-Asp adhesion receptors, such as platelet GPIIb-GPIIIa, vitronectin and fibronectin membrane receptors Uzan et al., 1988) , the intrachain and interchain disulphide-bond pattern outlined here for platelet GPIIb will most probably be conserved in other cytoadhesins.
Monoclonal-antibody epitopes
The localization of monoclonal-antibody epitopes is outlined in Scheme 1. The MI epitope is linear and it is localized somewhere between Pro-4 and Met-24 (or Met-31) of GPIIb/I, as found in the 20 kDa CNBr peptide from whole GPIIb and by CNBr cleavage of CMGPIIb,f. The epitope for M3 is also linear and it must be localized somewhere between Cys-826 and the C-terminal end of GPIIba, because this antibody recognizes both the 20 kDa CNBr and CM-19 kDa CNBr fragments, but not the Ch-85 kDa peptide, which contains the N- with the complete localization of the seven intrachain disulphide bonds and the N-glycosylation points in GPIIba. For the identification of the complete covalent structure of GPIIb, there are a number of features which remain to be determined. Among them: the localization of the O-glycosylation points, as well as the sugar sequences of the oligosaccharides; the molecular basis for the heterogeneity of GPIIb, which is already known from the existence of alloantigens localized in the asubunit (Kieffer et al., 1984) , and from the heterogeneity
